105
Views
4
CrossRef citations to date
0
Altmetric
Case Reports

Primary subcutaneous Alternaria alternata infection of the hand in an immunocompromised host

, , , , , & show all
Pages 543-547 | Received 19 Sep 2010, Accepted 15 Jan 2011, Published online: 07 Feb 2011

References

  • Boyce RD, Deziel PJ, Otley CC, . Phaeohyphomycosis due to Alternaria species in transplant recipients. Transpl Infect Dis 2010; 12:242–250.
  • Segner S, Jouret F, Durant JF, Marot L, Kanaan N. Cutaneous infection by Alternaria infectoria in a renal transplant patient. Transpl Infect Dis 2009; 11: 330–332.
  • Akman A, Sakalli Cakcak D, Ozhak Baysan B, . Cutaneous alternariosis in a patient with systemic lupus erythematosus. Lupus 2007; 16: 993–996.
  • Uenotsuchi T, Moroi Y, Urabe K, . Cutaneous alternariosis with chronic granulomatous disease. Eur J Dermato 2005; 15: 406–408.
  • Pereiro M Jr, Pereiro Ferreirós MM, De Hoog GS, Toribio J. Cutaneous infection caused by Alternaria in patients receiving tacrolimus. Med Mycol 2004; 42: 277–282.
  • Podda L, Fozza C, Nieddu R, . Breakthrough cutaneous alternariosis in a patient with acute lymphoblastic leukemia: clinical features and diagnostic issues. Leuk Lymphoma 2008; 49: 154–155.
  • Pastor FJ, Guarro J. Alternaria infections: laboratory diagnosis and relevant clinical features. Clin Microbiol Infect 2008; 14: 734–746.
  • Machet L, Jan V, Machet MC, Vaillant L, Lorette G. Cutaneous alternariosis: role of corticosteroid-induced cutaneous fragility. Dermatology 1996; 193: 342–344.
  • Ravandi F, O'Brien S. Immune defects in patients with chronic lymphocytic leukemia. Cancer Immunol Immunother 2006; 55: 197–209.
  • Salonen J, Nikoskelainen J. Lethal infections in patients with hematological malignancies. Eur J Haematol 1993; 51: 102–108.
  • Sabatelli F, Patel R, Mann PA, . In vitro activities of posaconazole, fluconazole, itraconazole, voriconazole, and amphotericin B against a large collection of clinically important molds and yeasts. Antimicrob Agents Chemother 2006; 50: 2009–2015.
  • Cuenca-Estrella M, Gomez-Lopez A, Mellado E, . Head-to-head comparison of the activities of currently available antifungal agents against 3,378 Spanish clinical isolates of yeasts and filamentous fungi. Antimicrob Agents Chemother. 2006; 50: 917–921.
  • Badali H, De Hoog GS, Curfs-Breuker I, Andersen B, Meis JF. In vitro activities of eight antifungal drugs against 70 clinical and environmental isolates of Alternaria species. J Antimicrob Chemother 2009; 63: 1295–1297.
  • Klein MB, Chang J. Management of hand and upper-extremity infections in heart transplant recipients. Plast Reconstr Surg 2000; 106: 598–601.
  • Heinz T, Perfect J, Schell W, . Soft-tissue fungal infections: surgical management of 12 immunocompromised patients. Plast Reconstr Surg 1996; 97: 1391–1399.
  • Kacániová M, Fikselová M. Mycological flora on tree fruits, crust, leaves and pollen Sorbus domestica L. Ann Agric Environ Med 2007; 14: 229–232.
  • González G, Mateo R, Medina A, Hinojo MJ, Jiménez M. Occurrence of mycotoxin producing fungi in bee pollen. Int J Food Microbiol 2005; 105: 1–9.
  • Cuétara MS, Alhambra A, Moragues MD, . Detection of (1-->3)-beta-D-glucan as an adjunct to diagnosis in a mixed population with uncommon proven invasive fungal diseases or with an unusual clinical presentation. Clin Vaccine Immunol 2009; 16: 423–426.
  • Iossifova Y, Reponen T, Sucharew H, Succop P, Vesper S. Use of (1-3)-beta-d-glucan concentrations in dust as a surrogate method for estimating specific fungal exposures. Indoor Air 2008; 18: 225–232.
  • Kappe R, Schulze-Berge A. New cause for false-positive results with the Pastorex Aspergillus antigen latex agglutination test. J Clin Microbiol 1993; 31: 2489–2490.
  • Ben-Ami R, Lasala PR, Lewis RE, Kontoyiannis DP. Lack of galactomannan reactivity in dematiaceous molds recovered from cancer patients with phaeohyphomycosis. Diagn Microbiol Infect Dis 2010; 66: 200–203.
  • Pascual A, Calandra T, Bolay S, . Voriconazole therapeutic drug monitoring in patients with invasive mycoses improves efficacy and safety outcomes. Clin Infect Dis 2008; 46: 201–211.
  • Hope WW, Billaud EM, Lestner J, Denning DW. Therapeutic drug monitoring for triazoles. Curr Opin Infect Dis 2008; 21: 580–586.
  • Benito M, Moreno A, Puig J, Rimola A. Alternariosis after liver transplant. Transplantation 2001; 72: 1840–1843.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.